David H. Vesole, MD, PhD, FACP

Co-Director, Myeloma Division
Director, Myeloma Research
John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey

Dr. David Vesole earned his doctorate degree in immunology at the Medical University of South Carolina, Charleston, and his medical degree from Northwestern University Medical School, Chicago. He was a postdoctoral fellow in the Department of Microbiology and Immunology at the University of Colorado Health Sciences Center, as well as a resident in internal medicine, and a fellow in hematology/oncology at the University of Iowa Hospitals and Clinics. Dr. Vesole is currently co-director, myeloma division, and director, myeloma research at the John Theurer Cancer Center at Hackensack University Medical Center.

Dr. Vesole is board certified by the American Board of Internal Medicine, the National Board of Medical Examiners, and holds memberships in the American College of Physicians, American Society for Blood and Marrow Transplantation, American Society of Clinical Oncology, and the American Society of Hematology. In addition, Dr. Vesole is on the Board of Directors of the Leukemia & Lymphoma Society (Wisconsin and New York affiliates), and is in the editorial board of Advances in Hematology.

A nationally recognized multiple myeloma expert, Dr. Vesole specializes in stem cell transplant for the treatment of multiple myeloma and other hematological diseases. He has authored hundreds of articles, abstracts and book chapters in peer-reviewed medical journals.

Faculty Disclosure
Dr. David Vesole has received honoraria related to speakers’ bureau activities from Celgene Corporation and Millennium: The Takeda Oncology Company

Dr. Vesole indicated that his presentation would include the discussion of unlabeled uses of commercial products or investigational/unapproved products not yet approved by the FDA for certain uses in the United States.
Last modified: July 18, 2017